MGH/MIT MORRIS UDALL CENTER OF EXCELLENCE IN PD RESEARCH

麻省总医院/麻省理工学院莫里斯尤德尔 PD 研究卓越中心

• 批准号: 6945849
• 负责人: ANNE B YOUNG
• 金额: $ 230.34万
• 依托单位: MASSACHUSETTS GENERAL HOSPITAL
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-09-30 至 2009-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6945849
• 关键词: Parkinson' s disease; alpha synuclein; clinical research; pathologic process

DESCRIPTION (provided by applicant): The MGH/MIT Morris Udall Center of Excellence in PD Research is taking a broad, collaborative and interactive approach to the study of Parkinson's disease. The Projects address critical questions concerning the selective vulnerability of dopamine neurons, the mechanism and consequences of Lewy body formation and alpha-synuclein aggregation, the neural systems consequences of parkinsonism and synuclein pathology, and molecular approaches for modifying this pathology. These issues will be explored using a range of systems, from yeast genetics, to mammalian cell culture, to rodent models to human postmortem material. The Center incorporates state-of-the-art technologies including high throughput yeast genetic screens to identify modifiers of synuclein aggregation and toxicity, viral vector gene transfer to study factors in mammalian cell culture and rodent models, multi-unit tetrode recordings to study striatal plasticity, fluorescence lifetime imaging to study protein-protein interactions, and laser capture microdissection and gene arrays to study transcriptional dysregulation. The Center has a Clinical and Training Core that provides care to patients with Parkinson's disease, gathers data on clinical features of the disease and response to therapy, solicits brain donations for neuropathological study, and trains outstanding clinician scientists to be future leaders in the field. The Center also has a Bioinformatics Core that serves to integrate and analyze data across the projects, and facilitate sharing of the information. The Administrative Core is charged with management of the Center and facilitating the sharing of information, ideas, and reagents among the investigators and with other components of the Udall Centers consortium. The investigators of the MGH/MIT Center are dedicated to a program of collaborative and interactive studies which will lead to better treatments for people with Parkinson's disease.

描述（由申请人提供）： MGH/MIT Morris Udall卓越PD研究中心正在采取广泛，协作和互动的方法来研究帕金森病。这些项目解决了有关多巴胺神经元的选择性脆弱性，路易体形成和α-突触核蛋白聚集的机制和后果，帕金森综合征和突触核蛋白病理学的神经系统后果，以及改变这种病理学的分子方法等关键问题。这些问题将使用一系列系统进行探索，从酵母遗传学，哺乳动物细胞培养，啮齿动物模型到人类死后材料。该中心采用了最先进的技术，包括高通量酵母遗传筛选，以确定突触核蛋白聚集和毒性的修饰剂，病毒载体基因转移，以研究哺乳动物细胞培养和啮齿动物模型中的因素，多单位四极录音研究纹状体可塑性，荧光寿命成像研究蛋白质-蛋白质相互作用，激光捕获显微切割和基因阵列研究转录失调。该中心有一个临床和培训中心，为帕金森病患者提供护理，收集有关疾病临床特征和治疗反应的数据，为神经病理学研究征集大脑捐赠，并培养优秀的临床科学家成为该领域的未来领导者。该中心还拥有一个生物信息学核心，用于整合和分析各个项目的数据，并促进信息共享。行政核心负责中心的管理，促进研究人员之间以及与Udall中心联盟的其他组成部分共享信息，想法和试剂。MGH/MIT中心的研究人员致力于一项合作和互动研究计划，这将为帕金森病患者提供更好的治疗方法。